We are live on ! Find out more
CTSO icon

Cytosorbents Corp

33 hedge funds and large institutions have $8.52M invested in Cytosorbents Corp in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $351K

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

12% more capital invested

Capital invested by funds: $7.63M → $8.52M (+$890K)

6% more funds holding

Funds holding: 3133 (+2)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
5
Reduced
9
Closed
6
Calls
$1.48M
Puts
$351K
Net Calls
+$1.13M
Net Calls Change
+$351K

CTSO Hedge Fund Activity: Q3 2015 in Review

33 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2015, worth a combined $8.52M — up 12% from $7.63M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CTSO positions and 6 closed out — a net gain of 2 holders — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Raymond James & Associates, opening a new position worth an estimated $855K. The largest seller was Morgan Stanley, cutting an estimated $761K.

  • 33 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2015, up from 31 in Q2 2015.
  • Funds reported $8.52M of Cytosorbents Corp stock for Q3 2015, up 12% quarter-over-quarter.
  • 8 funds opened new Cytosorbents Corp positions in Q3 2015 and 6 closed out, a net change of +2 holders.
  • The largest Cytosorbents Corp buyer in Q3 2015 was Raymond James & Associates, an estimated $855K added.
  • The largest Cytosorbents Corp seller in Q3 2015 was Morgan Stanley, an estimated $761K sold.

Based on aggregated 13F filings for Q3 2015.